Azenosertib
ZN-c3-003
Phase 1 small_molecule completed
Quick answer
Azenosertib for Osteosarcoma is a Phase 1 program (small_molecule) at Zentalis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zentalis Pharmaceuticals
- Indication
- Osteosarcoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed